PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 28, 2026Biological and Pharmaceutical Bulletin0 citationsOpen Access

Interlaboratory Method Validation for Determination of Polysorbate 80 for Analysis of mAbs

XYXiaojuan YuFWF. WangCYChuanfei Yu

Key Points

  • This research aims to validate a method for accurately measuring polysorbate 80 in therapeutic monoclonal antibodies.
  • Developed an HPLC method using an evaporative light scattering detector (ELSD) for PS80 analysis.
  • Conducted interlaboratory validation with different instruments and ELSD detectors.
  • Tested various immunoglobulin G (IgG) monoclonal antibodies and polysorbate 80 sources.
  • Assessed method robustness against mAb concentrations and interferences.
  • Successfully measured PS80 concentrations from 0.05 to 0.5 mg/mL.
  • Method tolerates up to 160 mg/mL of mAb interference through dilution or protein precipitation.
  • Validated method recommended for use in release and quality control for therapeutic mAbs.

Abstract

Polysorbate 80 (PS80) is a widely used surfactant in therapeutic monoclonal antibodies (mAbs) because it prevents mAb aggregation and stabilizes the drug product. Various analytical methods have been published and are available for measuring PS80, each with its own limitations. In this study, an HPLC method employing an evaporative light scattering detector (ELSD) was developed for multiproduct analysis of PS80. Method validation was conducted across multiple laboratories using different types of instruments and ELSD detectors. The method was validated using various immunoglobulin G (IgG) mAb molecules and different sources of PS80, with the results showing that it can accurately measure PS80 concentrations ranging from 0.05 to 0.5 mg/mL. Robustness tests demonstrated that the method tolerates up to 160 mg/mL mAb interference, through either sample dilution or protein precipitation. This method can be recommended as a release/quality control method for PS80 concentration determination in therapeutic mAbs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yu et al. (2026) studied this question.

synapsesocial.com/papers/69a286240a974eb0d3c00f1bhttps://doi.org/10.1248/bpb.b25-00345
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations2024 · 3 citations
  2. 2Detailed profiling of polysorbate 80 oxidative degradation products and hydrolysates using liquid chromatography–tandem mass spectrometry analysis2024 · 3 citations
  3. 3Phosphatidylcholine-Polysorbate 20-Based Mixed Micelles: A New Option to Prevent Protein Aggregation?2026
  4. 4Phosphatidylcholine-polysorbate 20-based mixed micelles : a new option to prevent protein aggregation?2026
  5. 5Rapid Quantification of Polysorbates in Complex In-process Formulation Buffers Using Variable Pathlength UV Spectrometry with a Slope-Intercept Strategy2026